Atlas Trials

5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Clinical trial NCT01041443 · COMPLETED

Trial details

NCT number
NCT01041443
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Acute Myeloid Leukemiade Novo Myelodysplastic SyndromesPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaSecondary Myelodysplastic SyndromesUntreated Adult Acute Myeloid Leukemia
Start date
2009-12-01
Primary completion
2013-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.